Header Logo

Connection

BAHEY SALEM to Biological Products

Back to Details
This is a "connection" page, showing publications BAHEY SALEM has written about Biological Products.
BAHEY SALEM
Connection Strength
0.050
Biological Products
  1. Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR. Blood Adv. 2025 Nov 11; 9(21):5460-5472.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.